Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Apply
NK Cells with Chemotherapy
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step